Take-Two (TTWO) Director Receives 254 Restricted Shares Under 2017 Plan
Rhea-AI Filing Summary
Take-Two Interactive Software, Inc. (TTWO) reported a Form 4 showing that Roland A. Hernandez, a director, received a grant of 254 shares of restricted common stock on 08/14/2025 under the Director compensation program and the Issuer's 2017 Stock Incentive Plan. The restricted shares were granted at a $0 price and vest on the first anniversary of the Pricing Date, where the number of shares was determined using the average closing price over the 30 trading days prior to August 14, 2025. Following the grant, Mr. Hernandez beneficially owned 9,760 shares. The filing was signed by an attorney-in-fact on behalf of Mr. Hernandez on 08/18/2025.
Positive
- Director alignment: The award vests over one year, aligning the director with long-term shareholder interests.
- Transparent valuation: Number of shares determined using the 30-trading-day average closing price prior to August 14, 2025.
- Increased insider ownership: Reporting person beneficially owns 9,760 shares after the transaction.
Negative
- None.
Insights
TL;DR: Routine director equity grant that modestly increases insider ownership and aligns the director with shareholder interests.
The Form 4 records a standard restricted stock award to a director under the company's director compensation program and 2017 Stock Incentive Plan. The grant of 254 restricted shares at $0 with a one-year vesting schedule is consistent with non-cash compensation typical for board service. The award increases the reporting person's beneficial holdings to 9,760 shares, representing a modest increase in insider ownership. There are no derivative transactions, sales, or unusual terms disclosed in the filing.
TL;DR: Standard governance practice: equity grant to a director that vests over time, supporting alignment with long-term shareholders.
This disclosure shows the company is compensating a director with restricted stock under its established plan, with vesting after one year from the Pricing Date. The mechanism for determining share quantity (30-day average price prior to the Pricing Date) is disclosed, indicating predictable valuation methodology. The Form 4 does not disclose any departures, accelerated vesting, or related-party transactions beyond the normal director award.